Companies: 10,795·Total market cap: $144.5T
Health Sciences Acquisitions Corporation 2

Health Sciences Acquisitions Corporation 2

HSAQNASDAQFinancial Services
$13.31
+$2.59(+24.16%)
Market Cap$149233051
P/E Ratio
52W High$13.8
52W Low$9.41

Health Sciences Acquisitions Corporation 2 (HSAQ) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · HSAQ · as of Jun 9, 2026

Activity summary

Buy transactions

7

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Health Sciences Acquisitions Corporation 2 insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

HSAQ insider buying and selling by quarter

HSAQ insider selling · HSAQ insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
14.3M7.2M0
2020 Q3
2022 Q3
2023 Q1
2023 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

HSAQ executive sell shares · HSAQ board member insider trading · HSAQ insider trading SEC filing

Showing 6 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Hochman David P

See Remarks · Director

Award

Date

Jul 20

Shares

165,000

Price

Value

View Form 4 on SEC.gov

ROSE ERIC A MD

Director

Other

Date

May 17

Shares

157

Price

$16.04

Value

$3K

View Form 4 on SEC.gov

Hochman David P

See Remarks · Director

Option

Date

Apr 12

Shares

11,160

Price

$15.00

Value

$167K

View Form 4 on SEC.gov

Hochman David P

See Remarks · Director

Option

Date

Apr 12

Shares

683

Price

$15.00

Value

$10K

View Form 4 on SEC.gov

RTW INVESTMENTS, LP

10 percent owner

Other

Date

Apr 13

Shares

502,133

Price

$15.00

Value

$7.53M ⚡

View Form 4 on SEC.gov

Medtronic plc

10 percent owner

Purchase

Date

Jan 30

Shares

6,835

Price

$9.28

Value

$63K

View Form 4 on SEC.gov

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About HSAQ insider trading

HSAQ insider trades

Health Sciences Acquisitions Corporation 2 (HSAQ) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including HSAQ. Over the past 12 months, 0 insiders have filed transactions with the SEC. HSAQ insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Health Sciences Acquisitions Corporation 2's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

HSAQ insider trading · 5 questions

The insiders of Health Sciences Acquisitions Corporation 2 (HSAQ) include executives and directors such as HSAQ, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

HSAQ board member insider tradingwho are HSAQ insidersHSAQ insider rosterHealth Sciences Acquisitions Corporation 2 executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026